Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

9473	Companies
185387	Keywords
117733	Articles
99269	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

BRIEF

published on 10/02/2025 at 07:05, 2 months 3 days ago

Newron Pharmaceuticals présente l'Evenamide au congrès ECNP 2025

Schizophrénie Essai Clinique Newron Pharmaceuticals Evenamide Congrès De L'ECNP
BRIEF

published on 10/02/2025 at 07:05, 2 months 3 days ago

Newron Pharmaceuticals Highlights Evenamide at ECNP Congress 2025

Clinical Trial Schizophrenia Newron Pharmaceuticals Evenamide ECNP Congress
PRESS RELEASE

published on 10/02/2025 at 07:00, 2 months 3 days ago

Newron to present new analyses from and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 38th ECNP Congress 2025
Newron Pharmaceuticals to present new analyses and updates on evenamide as treatment for schizophrenia at the 38th ECNP Congress 2025

Clinical Program Schizophrenia Newron Pharmaceuticals Evenamide ECNP Congress
BRIEF

published on 09/16/2025 at 07:05, 2 months 19 days ago

Newron Pharmaceuticals Unveils H1 2025 Results and Strategic Advancements

Strategic Partnerships Clinical Trials Newron Pharmaceuticals Evenamide Schizophrenia Treatment
BRIEF

published on 09/16/2025 at 07:05, 2 months 19 days ago

Newron Pharmaceuticals dévoile ses résultats du premier semestre 2025 et ses avancées stratégiques

Partenariats Stratégiques Essais Cliniques Newron Pharmaceuticals Evenamide Traitement De La Schizophrénie
PRESS RELEASE

published on 09/16/2025 at 07:00, 2 months 19 days ago

Newron presents H1 2025 results and provides business update
Newron Pharmaceuticals S.p.A. presents H1 2025 financial results and business update, focusing on evenamide therapy for treatment-resistant schizophrenia patients and strategic partnerships

Business Update Newron Pharmaceuticals Schizophrenia Treatment H1 2025 Results Evenamide Therapy
BRIEF

published on 09/05/2025 at 07:05, 3 months ago

Newron Pharmaceuticals to Reveal Evenamide Insights at 2025 WCBP

Newron Pharmaceuticals Evenamide Schizophrenia Treatment Clinical Trial Updates Glutamate Modulation
BRIEF

published on 09/05/2025 at 07:05, 3 months ago

Newron Pharmaceuticals dévoilera ses résultats sur l'Evenamide au WCBP 2025

Newron Pharmaceuticals Evenamide Traitement De La Schizophrénie Mises À Jour Des Essais Cliniques Modulation Du Glutamate
PRESS RELEASE

published on 09/05/2025 at 07:00, 3 months ago

Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)
Newron Pharmaceuticals to present data on evenamide as add-on treatment for schizophrenia at 2025 WCBP. Focus on efficacy, safety, and mechanism of action. Landmark studies showcased

Clinical Program Schizophrenia Newron Pharmaceuticals Evenamide WCBP
BRIEF

published on 08/12/2025 at 07:05, 3 months 24 days ago

Newron lance l'étude de phase III ENIGMA-TRS pour la schizophrénie résistante au traitement

Newron Pharmaceuticals Evenamide Traitement De La Schizophrénie Étude De Phase III Thérapie TRS

1 2 ... 8

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 39 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 44 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 14 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 9 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 14 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:05, 8 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 12 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 12 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 13 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 13 minutes ago

Le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) croît et est sur le point de franchir la barre des 500 millions

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 59 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 14 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 14 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 29 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 29 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE